Emiepifisiodesi nel trattamento del ginocchio valgo in bambini con malattia esostosante e bambini con ginocchio valgo idiopatico

Title

Code

GGMO I

Type

Osservazionale

Start Year

2020

Status

Terminato

Principal Investigator

051-6366186, 340-2643380

giovanni.trisolino@ior.it

Trisolino Giovanni, MD

Pediatric Orthopedics and Traumatology

Operational unit that carry out the study

complex unit

Ortopedia e Traumatologia Pediatrica

Director

Rocca Gino, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio clinico n. GGMO IGGMO I

Wednesday 31 August 2022, 17:21

PG0011002_2020_GGMO IGGMO I.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Emiepifisiodesi nel trattamento del ginocchio valgo in bambini con malattia esostosante e bambini con ginocchio valgo idiopatico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Emiepifisiodesi nel trattamento del ginocchio valgo in bambini con malattia esostosante e bambini con ginocchio valgo idiopatico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in